The Biomarkers Consortium

descriptionPublicationkeyboard_double_arrow_right Article 31 Oct 2014 English Publisher:Springer Science and Business Media LLCJournal:Nature Reviews Drug Discovery, volume 13, pages 791-792 (issn: 1474-1776, eissn: 1474-1784,

Copyright policy )

Authors: David, Wholley;

doi: 10.1038/nrd4439

pmid: 25359363

The Biomarkers Consortium

- Summary
- Subjects
- Metrics

Abstract

The Biomarkers Consortium is a public–private biomedical research partnership that seeks to develop and qualify biomarkers across a broad range of diseases in order to accelerate the development of new medicines and improve patient care.

Related Organizations

Foundation for the National Institutes of Health
United States

Keywords

Humans, Patient Care, Cooperative Behavior, Public-Private Sector Partnerships, Biomarkers

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	17
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%